New York State Common Retirement Fund
TXG icon

New York State Common Retirement Fund’s 10x Genomics TXG Stock Holding History

New York State Common Retirement Fund’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
43,137
+7,120
+20% +$187K ﹤0.01% 1536
2026
Q1 		$765K Hold
36,017
– – ﹤0.01% 1754
2025
Q4 		$587K Buy
36,017
+1,533
+4% +$23.2K ﹤0.01% 1907
2025
Q3 		$403K Buy
34,484
+8,600
+33% +$112K ﹤0.01% 2019
2025
Q2 		$300K Sell
25,884
-17,081
-40% -$156K ﹤0.01% 2094
2025
Q1 		$375K Sell
42,965
-433,373
-91% -$5.46M ﹤0.01% 1987
2024
Q4 		$6.84M Sell
476,338
-39,010
-8% -$616K 0.01% 960
2024
Q3 		$11.6M Sell
515,348
-49,790
-9% -$1.03M 0.02% 707
2024
Q2 		$11M Sell
565,138
-91,571
-14% -$2.4M 0.01% 763
2024
Q1 		$24.6M Buy
656,709
+13,794
+2% +$606K 0.03% 441
2023
Q4 		$36M Buy
642,915
+3,994
+0.6% +$174K 0.05% 317
2023
Q3 		$26.4M Sell
638,921
-43,363
-6% -$2.26M 0.04% 395
2023
Q2 		$38.1M Sell
682,284
-30,886
-4% -$1.67M 0.05% 327
2023
Q1 		$39.8M Buy
713,170
+160,989
+29% +$7.52M 0.05% 313
2022
Q4 		$20.1M Sell
552,181
-55,772
-9% -$1.82M 0.03% 558
2022
Q3 		$17.3M Sell
607,953
-5,815
-0.9% -$222K 0.03% 582
2022
Q2 		$27.8M Buy
613,768
+317,447
+107% +$16.5M 0.04% 414
2022
Q1 		$22.5M Buy
296,321
+58,882
+25% +$5.15M 0.02% 578
2021
Q4 		$35.4M Buy
237,439
+1,500
+0.6% +$230K 0.04% 432
2021
Q3 		$34.3M Sell
235,939
-470
-0.2% -$80.7K 0.04% 438
2021
Q2 		$46.3M Buy
236,409
+75,798
+47% +$13.7M 0.05% 346
2021
Q1 		$29.1M Buy
160,611
+23,713
+17% +$4.09M 0.03% 508
2020
Q4 		$19.4M Buy
136,898
+51,998
+61% +$7.55M 0.02% 657
2020
Q3 		$10.6M Buy
84,900
+2,000
+2% +$210K 0.01% 828
2020
Q2 		$7.4M Buy
+82,900
New +$6.46M 0.01% 997

Other funds holding TXG

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

New York State Common Retirement Fund's TXG Position: Q2 2026 in Review

New York State Common Retirement Fund increased its 10x Genomics (TXG) stake by 20% in Q2 2026, buying an estimated $187K and bringing the position to 43,137 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

New York State Common Retirement Fund first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. The position peaked at $46.3M in Q2 2021. 122 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • New York State Common Retirement Fund held 43,137 shares of 10x Genomics worth $1.65M as of Q2 2026.
  • New York State Common Retirement Fund bought 7,120 10x Genomics shares in Q2 2026, an estimated $187K.
  • 10x Genomics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1536 holding.
  • New York State Common Retirement Fund first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's 10x Genomics position peaked at $46.3M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.